Drug intelligence / Profile preview

Yangxian Fengdian Wan

Development stage
Unknown
Lead developer
Tianjin Pharmaceutical Da Ren Tang Group
Modality
Small Molecules
Administration
Oral
01

Overview

Yangxian Fengdian Wan is a traditional Chinese medicine (TCM) multi-herb formulation developed and manufactured by Tianjin Pharmaceutical Da Ren Tang. It is an oral medication indicated for the treatment of epilepsy and seizure disorders, specifically those categorized in TCM as being caused by "wind-phlegm blocking the orifices." The formulation typically includes a complex mixture of herbal, mineral, and animal-derived ingredients such as Realgar (雄黄), Hematite (赭石), Magnetite (磁石), Pinellia (半夏), Arisaema cum Bile (胆南星), Centipede (蜈蚣), and Scorpion (全蝎). These components work synergistically to clear phlegm, open sensory orifices, and calm the spirit (Shen), thereby addressing symptoms like sudden loss of consciousness, convulsions, and foaming at the mouth. As a traditional formulation, it does not have a single defined molecular target but is recognized in China as an approved pharmaceutical product for managing epileptic conditions.

Brand names
Da Ren Tang
Other names
羊痫疯癫丸Yangxian Fengdian Pills

Beyond the preview

Go deeper on Yangxian Fengdian Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yangxian Fengdian Wan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call